Overcome the challenges of cell differentiation and reprogramming with opti-ox™, precision reprogramming

Current methods to regenerate cells from human induced Pluripotent Stem Cells (iPSCs) - directed differentiation and cellular reprogramming - lack reproducibility and scalability. This raises challenges for disease research, drug discovery, and cell therapy development due to unreliable data and long experimental timelines.

A technology that enables the reproducible, consistent, and scalable production of physiologically relevant human cell models for any cell type would mean scientists can be more confident in their experiments. opti-ox™, a first-of-its-kind precision reprogramming technology, meets all of these requirements by controlling the precise expression of cell-fate determining transcription factors without gene silencing.

In this infographic, we outline traditional methods to generate cells from human iPSCs and compare these to the new precision reprogramming technology enabled by opti-ox.